Results 111 to 120 of about 35,850 (218)
ABSTRACT Objectives To analyze the presence, framing, and cultural accessibility of HPV vaccination messaging related to oropharyngeal squamous cell carcinoma (OPSCC) prevention among health institutions serving Middle Eastern and North African (MENA) populations in the United States.
Yehya Main Maitah +4 more
wiley +1 more source
Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy
Barrier‐defined strategies for cold‐to‐hot tumor conversion. Cold tumors include immune‐desert and immune‐excluded states marked by poor antigen visibility, limited T‐cell priming, stromal or vascular exclusion, metabolic stress and suppressive immune programs.
Xiao Ge +5 more
wiley +1 more source
Engineered Bacterial Membranes as Next‐Generation Platforms for Cancer Immunotherapy
Engineered bacterial membrane platforms, including outer membrane vesicles, bacterial ghosts, genetically engineered membranes, and hybrid bacterial–tumor membranes, integrate tumor antigen presentation with intrinsic immune stimulation. These platforms promote dendritic‐cell activation, T‐cell priming, pyroptosis, and synergistic responses with ...
Hafiza Aasia Malik +4 more
wiley +1 more source
ABSTRACT Background Persistent oncogenic HPV infection can cause cervical epithelial changes leading to premalignant lesions such as CIN2. Active surveillance, a conservative option, reduces exposure to excisional risks while allowing timely treatment when needed. However, little is known about clinicians' perspectives, acceptability, and experience of
Dan Luo +7 more
wiley +1 more source
In transformation zone type 3, a systematic multiple biopsy protocol improved CIN2+ detection, particularly in high‐grade referrals, whereas yield remained limited in low‐grade referral cases. DSI‐assisted colposcopy did not increase biopsy sensitivity’.
Vibe Munk Bertelsen +4 more
wiley +1 more source
Resilience to HPV vaccine safety scares in seven countries. [PDF]
Ellingson MK +11 more
europepmc +1 more source
HPV vaccine: the key to a powerful shield against cancer. [PDF]
Kılavuz M +3 more
europepmc +1 more source
HPV vaccine for adolescents in China: what is the next step? [PDF]
The Lancet Regional Health-Western Pacific.
europepmc +1 more source
Adverse events following HPV vaccine reported to the Vaccine Adverse Event Reporting System. [PDF]
Zhang S +5 more
europepmc +1 more source
A Scoping Review of Influences on HPV Vaccine Uptake in the Rural US. [PDF]
Sheinfeld Gorin S +6 more
europepmc +1 more source

